Related Experiment Video
Updated: Oct 7, 2026

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
COVID-19 pandemic: A multidimensional analysis and the strategic role played by developing countries vaccine
Rajinder Kumar Suri1, Dominique Maugeais2, Kapil Maithal3
1DCVMN International, Route de Crassier 7, 1262 Eysins Nyon, Switzerland.
Abstract:
Contribution of Developing Countries Vaccine Manufacturers (DCVMs) in the vaccine response to the COVID-19 pandemic crisis in 2021-2022 has been paramount, totaling 9.81 billion of the 15.91 billion vaccine doses distributed [1]. However, since many DCVMs acted as licensees or contract-manufacturing organizations (CMOs) of alternate developers, global understanding and knowledge of the magnitude of this contribution is understated. This paper aims at documenting and analyzing in further details the critical and central role played by DCVMs in the vaccine response to tackle the COVID-19 pandemic.
Related Concept Videos
Vaccine Production
Vaccines
Coronavirus
Smallpox
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Infectious Diseases and Their Occurrence